|
1
|
Collard RM, Boter H, Schoevers RA and
Voshaar RC Oude: Prevalence of frailty in community-dwelling older
persons: A systematic review. J Am Geriatr Soc. 60:1487–1492. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fujishima M and Kiyohara Y: Incidence and
risk factors of dementia in a defined elderly Japanese population:
The Hisayama study. Ann NY Acad Sci. 977:1–8. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Andersen K, Launer LJ, Dewey ME, Letenneur
L, Ott A, Copeland JR, Dartigues JF, Kragh-Sorensen P, Baldereschi
M, Brayne C, et al: Gender differences in the incidence of AD and
vascular dementia: The EURODEM Studies. EURODEM Incidence Research
Group. Neurology. 53:1992–1997. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gao S, Hendrie HC, Hall KS and Hui S: The
relationships between age, sex, and the incidence of dementia and
Alzheimer disease: A meta-analysis. Arch Gen Psychiatry.
55:809–815. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Read S, Pedersen NL, Gatz M, Berg S,
Vuoksimaa E, Malmberg B, Johansson B and McClearn GE: Sex
differences after all those years? Heritability of cognitive
abilities in old age. J Gerontol B Psychol Sci Soc Sci.
61:P137–P143. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li R and Singh M: Sex differences in
cognitive impairment and Alzheimer's disease. Front
Neuroendocrinol. 35:385–403. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Letenneur L, Gilleron V, Commenges D,
Helmer C, Orgogozo JM and Dartigues JF: Are sex and educational
level independent predictors of dementia and Alzheimer's disease?
Incidence data from the PAQUID project. J Neurol Neurosurg
Psychiatry. 66:177–183. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fratiglioni L, Viitanen M, Von Strauss E,
Tontodonati V, Herlitz A and Winblad B: Very old women at highest
risk of dementia and Alzheimer's disease: Incidence data from the
kungsholmen project, stockholm. Neurology. 48:132–138. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ott A, Breteler MM, Van Harskamp F,
Stijnen T and Hofman A: Incidence and risk of dementia. The
rotterdam study. Am J Epidemiol. 147:574–580. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Matthews F, Brayne C, et al: Medical
Research Council Cognitive Function and Ageing Study Investigators:
The incidence of dementia in England and Wales: Findings from the
five identical sites of the MRC CFA study. PLoS Med. 2:e1932005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Roubenoff R: Sarcopenia: A major
modifiable cause of frailty in the elderly. J Nutr Health Aging.
4:140–142. 2000.PubMed/NCBI
|
|
12
|
Baumgartner RN, Koehler KM, Gallagher D,
Romero L, Heymsfield SB, Ross RR, Garry PJ and Lindeman RD:
Epidemiology of sarcopenia among the elderly in New Mexico. Am J
Epidemiol. 147:755–763. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Morley JE, Anker SD and von Haehling S:
Prevalence, incidence, and clinical impact of sarcopenia: Facts,
numbers, and epidemiology-update 2014. J Cachexia Sarcopenia
Muscle. 5:253–259. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Legrand D, Vaes B, Mathei C, Swine C and
Degryse JM: The prevalence of sarcopenia in very old individuals
according to the European consensus definition: Insights from the
BELFRAIL study. Age Ageing. 42:727–734. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Masanes F, Culla A, Navarro-Gonzalez M,
Navarro-Lopez MC, Sacanella E, Torres B and Lopez-Soto A:
Prevalence of sarcopenia in healthy community-dwelling elderly in
an urban area of Barcelona (Spain). J Nutr Health Aging.
16:184–187. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim YS, Lee Y, Chung YS, Lee DJ, Joo NS,
Hong D, Song Ge, Kim HJ, Choi YJ and Kim KM: Prevalence of
sarcopenia and sarcopenic obesity in the Korean population based on
the fourth Korean national health and nutritional examination
surveys. J Gerontol A Biol Sci Med Sci. 67:1107–1113. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu IC, Lin CC, Hsiung CA, Wang CY, Wu CH,
Chan DC, Li TC, Lin WY, Huang KC, Chen CY, et al: Epidemiology of
sarcopenia among community-dwelling older adults in Taiwan: A
pooled analysis for a broader adoption of sarcopenia assessments.
Geriatr Gerontol Int. 14:(Suppl 1). S52–S60. 2014. View Article : Google Scholar
|
|
18
|
Jack CR Jr, Knopman DS, Jagust WJ,
Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P, Wiste HJ,
Weigand SD, et al: Tracking pathophysiological processes in
Alzheimer's disease: An updated hypothetical model of dynamic
biomarkers. Lancet Neurol. 12:207–216. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Villemagne VL, Burnham S, Bourgeat P,
Brown B, Ellis KA, Salvado O, Szoeke C, Macaulay SL, Martins R,
Maruff P, et al: Amyloid β deposition, neurodegeneration, and
cognitive decline in sporadic Alzheimer's disease: A prospective
cohort study. Lancet Neurol. 12:357–67. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Evans DA, Funkenstein HH, Albert MS,
Scherr PA, Cook NR, Chown MJ, Hebert LE, Hennekens CH and Taylor
JO: Prevalence of Alzheimer's disease in a community population of
older persons. Higher than previously reported. JAMA.
262:2551–2556. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hy LX and Keller DM: Prevalence of AD
among whites: A summary by levels of severity. Neurology.
55:198–204. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jack CR Jr, Wiste HJ, Weigand SD, Knopman
DS, Vemuri P, Mielke MM, Lowe V, Senjem ML, Gunter JL, Machulda MM,
et al: Age, sex, and APOE ε4 effects on memory, brain structure,
and β-amyloid across the adult life span. JAMA Neurol. 72:511–519.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Coffey CE, Lucke JF, Saxton JA, Ratcliff
G, Unitas LJ, Billig B and Bryan RN: Sex differences in brain
aging: A quantitative magnetic resonance imaging study. Arch
Neurol. 55:169–179. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Murphy DG, DeCarli C, McIntosh AR, Daly E,
Mentis MJ, Pietrini P, Szczepanik J, Schapiro MB, Grady CL, Horwitz
B and Rapoport SI: Sex differences in human brain morphometry and
metabolism: An in vivo quantitative magnetic resonance imaging and
positron emission tomography study on the effect of aging. Arch Gen
Psychiatry. 53:585–594. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Raz N, Gunning FM, Head D, Dupuis JH,
McQuain J, Briggs SD, Loken WJ, Thornton AE and Acker JD: Selective
aging of the human cerebral cortex observed in vivo: Differential
vulnerability of the prefrontalgray matter. Cereb Cortex.
7:268–282. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pruessner JC, Collins DL, Pruessner M and
Evans AC: Age and gender predict volume decline in the anterior and
posterior hippocampus in early adulthood. J Neurosci. 21:194–200.
2001.PubMed/NCBI
|
|
27
|
Bouix S, Pruessner JC, Collins D Louis and
Siddiqi K: Hippocampal shape analysis using medial surfaces.
Neuroimage. 25:1077–1089. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kokmen E, Beard CM, O'Brien PC and Kurland
LT: Epidemiology of dementia in Rochester, Minnesota. Mayo Clin
Proc. 71:275–282. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nitrini R, Caramelli P, Herrera E Jr,
Bahia VS, Caixeta LF, Radanovic M, Anghinah R, Charchat-Fichman H,
Porto CS, Carthery MT, et al: Incidence of dementia in a
community-dwelling Brazilian population. Alzheimer Dis Assoc
Disord. 18:241–246. 2004.PubMed/NCBI
|
|
30
|
Edland SD, Rocca WA, Petersen RC, Cha RH
and Kokmen E: Dementia and Alzheimer disease incidence rates do not
vary by sex in Rochester, Minn. Arch Neurol. 59:1589–1593. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Katz MJ, Lipton RB, Hall CB, Zimmerman ME,
Sanders AE, Verghese J, Dickson DW and Derby CA: Age-specific and
sex-specific prevalence and incidence of mild cognitive impairment,
dementia, and Alzheimer dementia in blacks and whites: A report
from the einstein aging study. Alzheimer Dis Assoc Disord.
26:335–343. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ruitenberg A, Ott A, van Swieten JC,
Hofman A and Breteler MM: Incidence of dementia: Does gender make a
difference? Neurobiol Aging. 22:575–580. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Vest RS and Pike CJ: Gender, sex steroid
hormones, and Alzheimer's disease. Horm Behav. 63:301–307. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ruan Q, Yu Z, Chen M, Bao Z, Li J and He
W: Cognitive frailty, a novel target for the prevention of elderly
dependency. Ageing Res Rev. 20:1–10. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Panza F, Solfrizzi V, Barulli MR,
Santamato A, Seripa D, Pilotto A and Logroscino G: Cognitive
Frailty: A systematic review of epidemiological and neurobiological
evidence of an age-related clinical condition. Rejuvenation Res.
18:389–412. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Clegg A, Young J, Iliffe S, Rikkert MO and
Rockwood K: Frailty in elderly people. Lancet. 381:752–762. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Halil M, Kizilarslanoglu M Cemal, Kuyumcu
M Emin, Yesil Y and Jentoft AJ Cruz: Cognitive aspects of frailty:
Mechanisms behind the link between frailty and cognitive
impairment. J Nutr Health Aging. 9:276–283. 2015. View Article : Google Scholar
|
|
38
|
Chahal HS and Drake WM: The endocrine
system and ageing. J Pathol. 211:173–180. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lamberts SW, van den Beld AW and van der
Lely AJ: The endocrinology of aging. Science. 278:419–424. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jian J, Pelle E and Huang X: Iron and
menopause: Does increased iron affect the health of postmenopausal
women? Antioxid Redox Signal. 11:2939–2943. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Goodman-Gruen D and Barrett-Connor E: Sex
differences in the association of endogenous sex hormone levels and
glucose tolerance status in older men and women. Diabetes Care.
23:912–918. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Militello A, Vitello G, Lunetta C, Toscano
A, Maiorana G, Piccoli T and La Bella V: The serum level of free
testosterone is reduced in amyotrophic lateral sclerosis. J Neurol
Sci. 195:67–70. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Paoletti AM, Congia S, Lello S, Tedde D,
Orrù M, Pistis M, Pilloni M, Zedda P, Loddo A and Melis GB: Low
androgenization index in elderly women and elderly men with
Alzheimer's disease. Neurology. 62:301–303. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Longcope C: Androgen metabolism and the
menopause. Semin Reprod Endocrinol. 16:111–115. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Rosario ER, Chang L, Head EH, Stanczyk FZ
and Pike CJ: Brain levels of sex steroid hormones in men and women
during normal aging and in Alzheimer's disease. Neurobiol Aging.
32:604–613. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ferrini RL and Barrett-Connor E: Sex
hormones and age: A cross-sectional study of testosterone and
estradiol and their bioavailable fractions in community-dwelling
men. Am J Epidemiol. 147:750–754. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Harman SM, Metter EJ, Tobin JD, Pearson J,
Blackman MR, et al: Baltimore Longitudinal Study of Aging:
Longitudinal effects of aging on serum total and free testosterone
levels in healthy men. Baltimore longitudinal study of aging. J
Clin Endocrinol Metab. 86:724–731. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Samaras N, Samaras D, Lang PO, Forster A,
Pichard C, Frangos E and Meyer P: A view of geriatrics through
hormones. What is the relation between andropause and well-known
geriatric syndromes? Maturitas. 74:213–219. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Morley JE and Malmstrom TK: Frailty,
sarcopenia, and hormones. Endocrinol Metab Clin North Am.
42:391–405. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Mohr BA, Bhasin S, Kupelian V, Araujo AB,
O'Donnell AB and McKinlay JB: Testosterone, sex hormone-binding
globulin, and frailty in older men. J Am Geriatr Soc. 55:548–555.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Cappola AR, Xue QL and Fried LP: Multiple
hormonal deficiencies in anabolic hormones are found in frail older
women: The women's health and aging studies. J Gerontol A Biol Sci
Med Sci. 64:243–248. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Morley JE, Kaiser F, Raum WJ, Perry HM
III, Flood JF, Jensen J, Silver AJ and Roberts E: Potentially
predictive and manipulable blood serum correlates of aging in the
healthy human male: Progressive decreases in bioavailable
testosterone, dehydroepiandrosterone sulfate, and the ratio of
insulin-like growth factor 1 to growth hormone. Proc Natl Acad Sci
USA. 94:7537–7542. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Cawthon PM, Ensrud KE, Laughlin GA, Cauley
JA, Dam TT, Barrett-Conno E, Fink HA, Hoffman AR, Lau E, Lane NE,
et al: Sex hormones and frailty in older men: The osteoporotic
fractures in men (MrOS) study. J Clin Endocrinol Metab.
94:3806–3815. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Auyeung TW, Lee JS, Kwok T, Leung J,
Ohlsson C, Vandenput L, Leung PC and Woo J: Testosterone but not
estradiol level is positively related to muscle strength and
physical performance independent of muscle mass: A cross-sectional
study in 1489 older men. Eur J Endocrinol. 164:811–817. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Travison TG, Nguyen AH, Naganathan V,
Stanaway FF, Blyth FM, Cumming RG, Le Couteur DG, Sambrook PN and
Handelsman DJ: Changes in reproductive hormone concentrations
predict the prevalence and progression of the frailty syndrome in
older men: The concord health and ageing in men project. J Clin
Endocrinol Metab. 96:2464–2474. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Carcaillon L, Blanco C, Alonso-Bouzón C,
Alfaro-Acha A, Garcia-García FJ and Rodriguez-Mañas L: Sex
differences in the association between serum levels of testosterone
and frailty in an elderly population: The toledo study for healthy
aging. PLoS One. 7:e324012012. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Pilz KS, Konar Y, Vuong QC, Bennett PJ and
Sekuler AB: Age-related changes in matching novel objects across
viewpoints. Vision Res. 51:1958–1965. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Neufang S, Specht K, Hausmann M, Güntürkün
O, Herpertz-Dahlmann B, Fink GR and Konrad K: Sex differences and
the impact of steroid hormones on the developing human brain. Cereb
Cortex. 19:464–473. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Manly JJ, Merchant CA, Jacobs DM, Small
SA, Bell K, Ferin M and Mayeux R: Endogenous estrogen levels and
Alzheimer's disease among postmenopausal women. Neurology.
54:833–837. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Yue X, Lu M, Lancaster T, Cao P, Honda S,
Staufenbiel M, Harada N, Zhong Z, Shen Y and Li R: Brain estrogen
deficiency accelerates Abeta b plaque formation in an Alzheimer's
disease animal model. Proc Natl Acad Sci USA. 102:19198–19203.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Rapp PR, Morrison JH and Roberts JA:
Cyclic estrogen replacement improves cognitive function in aged
ovariectomized rhesus monkeys. J Neurosci. 23:5708–5714.
2003.PubMed/NCBI
|
|
62
|
Kesler SR, Garrett A, Bender B, Yankowitz
J, Zeng SM and Reiss AL: Amygdala and hippocampal volumes in turner
syndrome: A high-resolution MRI study of X-monosomy.
Neuropsychologia. 42:1971–1978. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Craig MC, Maki PM and Murphy DG: The
women's health initiative memory study: Findings and implications
for treatment. Lancet Neurol. 4:190–194. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Moffat SD, Zonderman AB, Metter EJ, Kawas
C, Blackman MR, Harman SM and Resnick SM: Free testosterone and
risk for Alzheimer disease in older men. Neurology. 62:188–193.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Hogervorst E, Combrinck M and Smith AD:
Testosterone and gonadotropin levels in men with dementia. Neuro
Endocrinol Lett. 24:203–208. 2003.PubMed/NCBI
|
|
66
|
Moffat SD, Zonderman AB, Metter EJ,
Blackman MR, Harman SM and Resnick SM: Longitudinal assessment of
serum free testosterone concentration predicts memory performance
and cognitive status in elderly men. J Clin Endocrinol Metab.
87:5001–5007. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Rosario ER, Carroll J and Pike CJ:
Testosterone regulation of Alzheimer-like neuropathology in male
3xTg-AD mice involves both estrogen and androgen pathways. Brain
Res. 1359:281–290. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Emmelot-Vonk MH, Verhaar HJ, Pour HR
Nakhai, Aleman A, Lock TM, Bosch JL, Grobbee DE and van der Schouw
YT: Effect of testosterone supplementation on functional mobility,
cognition, and other parameters in older men: A randomized
controlled trial. JAMA. 299:39–52. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Ebner NC, Kamin H, Diaz V, Cohen RA and
MacDonald K: Hormones as ‘difference makers’ in cognitive and
socioemotional aging processes. Front Psychol. 5:15952015.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Giefing-Kröll C, Berger P, Lepperdinger G
and Grubeck-Loebenstein B: How sex and age affect immune responses,
susceptibility to infections, and response tovaccination. Aging
Cell. 14:309–321. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Candore G, Balistreri CR, Colonna-Romano
G, Lio D, Listì F, Vasto S and Caruso C: Gender-related
immune-inflammatory factors, age-related diseases, and longevity.
Rejuvenation Res. 13:292–297. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Vrachnis N, Zygouris D, Iliodromiti Z,
Daniilidis A, Valsamakis G and Kalantaridou S: Probing the impact
of sex steroids and menopause-related sex steroid deprivation on
modulation of immune senescence. Maturitas. 78:174–178. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Zhang G, Li J, Purkayastha S, Tang Y,
Zhang H, Yin Y, Li B, Liu G and Cai D: Hypothalamic programming of
systemic ageing involving IKK-β, NF-κB and GnRH. Nature.
497:211–216. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Blasko I, Stampfer-Kountchev M, Robatscher
P, Veerhuis R, Eikelenboom P and Grubeck-Loebenstein B: How chronic
inflammation can affect the brain and support the development of
Alzheimer's disease in old age: The role of microglia and
astrocytes. Aging Cell. 3:169–176. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Schaap LA, Pluijm SM, Deeg DJ and Visser
M: Inflammatory markers and loss of muscle mass (sarcopenia) and
strength. Am J Med. 119:526.e9–17. 2006. View Article : Google Scholar
|
|
76
|
Fulop T, Larbi A, Witkowski JM, McElhaney
J, Loeb M, Mitnitski A and Pawelec G: Aging, frailty and
age-related diseases. Biogerontology. 11:547–563. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Ruan Q, Qian F and Yu Z: Effects of
polymorphisms in immunity-related genes on the immune system and
successful aging. Curr Opin Immunol. 29:49–55. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Lane JM, Serota AC and Raphael B:
Osteoporosis: Differences and similarities in male and female
patients. Orthop Clin North Am. 37:601–609. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Kalyani RR, Corriere M and Ferrucci L:
Age-related and disease-related muscle loss: The effect of
diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol.
2:819–829. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Tagliaferri C, Wittrant Y, Davicco MJ,
Walrand S and Coxam V: Muscle and bone, two interconnected tissues.
Ageing Res Rev. 21:55–70. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Viña J and Lloret A: Why women have more
Alzheimer's disease than men: Gender and mitochondrial toxicity of
amyloid-beta peptide. J Alzheimers Dis. 20:(Suppl 2). S527–S533.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Roberts RO, Geda YE, Knopman DS, Cha RH,
Pankratz VS, Boeve BF, Tangalos EG, Ivnik RJ, Mielke MM and
Petersen RC: Cardiac disease associated with increased risk of
nonamnestic cognitive impairment: Stronger effect on women. JAMA
Neurol. 70:374–382. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Roberts RO, Knopman DS, Geda YE, Cha RH,
Pankratz VS, Baertlein L, Boeve BF, Tangalos EG, Ivnik RJ, Mielke
MM and Petersen RC: Association of diabetes with amnestic and
nonamnestic mild cognitive impairment. Alzheimers Dement. 10:18–26.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Richard E, Reitz C, Honig LH, Schupf N,
Tang MX, Manly JJ, Mayeux R, Devanand D and Luchsinger JA:
Late-life depression, mild cognitive impairment, and dementia. JAMA
Neurol. 70:374–382. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Nourhashémi F, Andrieu S,
Gillette-Guyonnet S, Reynish E, Albarède JL, Grandjean H and Vellas
B: Is there a relationship between fat-free soft tissue mass and
low cognitive function? Results from a study of 7,105 women. J Am
Geriatr Soc. 50:1796–1801. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Auyeung TW, Lee JS, Kwok T and Woo J:
Physical frailty predicts future cognitive decline-a four-year
prospective study in 2737 cognitively normal older adults. J Nutr
Health Aging. 15:690–694. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Burns JM, Johnson DK, Watts A, Swerdlow RH
and Brooks WM: Reduced lean mass in early Alzheimer disease and its
association with brain atrophy. Arch Neurol. 67:428–433. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
de la Monte SM: Contributions of brain
insulin resistance and deficiency in amyloid-related
neurodegeneration in Alzheimer's disease. Drugs. 72:49–66. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Kalyani RR, Varadhan R, Weiss CO, Fried LP
and Cappola AR: Frailty status and altered glucose-insulin
dynamics. J Gerontol A Biol Sci Med Sci. 67:1300–1306. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Gould E, Woolley CS, Frankfurt M and
McEwen BS: Gonadal steroids regulate dendritic spine density in
hippocampal pyramidal cells in adulthood. J Neurosci. 10:1286–1291.
1990.PubMed/NCBI
|
|
91
|
Dumitriu D, Hao J, Hara Y, Kaufmann J,
Janssen WG, Lou W, Rapp PR and Morrison JH: Selective changes in
thin spine density and morphology in monkey prefrontal cortex
correlate with aging-related cognitive impairment. J Neurosci.
30:7507–7515. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Pereira AC, Lambert HK, Grossman YS,
Dumitriu D, Waldman R, Jannetty SK, Calakos K, Janssen WG, McEwen
BS and Morrison JH: Glutamatergic regulation prevents
hippocampal-dependent age-related cognitive decline through
dendritic spine clustering. Proc Natl Acad Sci USA.
111:18733–18738. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Galea LA, Wainwright SR, Roes MM,
Duarte-Guterman P, Chow C and Hamson DK: Sex, hormones, and
neurogenesis in the hippocampus: Hormonal modulation of
neurogenesis and potential functional implications. J
Neuroendocrinol. 25:1039–1061. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Spencer JL, Waters EM, Romeo RD, Wood GE,
Milner TA and McEwen BS: Uncovering the mechanisms of estrogen
effects on hippocampal function. Front Neuroendocrinol. 29:219–237.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Long J, He P, Shen Y and Li R: New
evidence of mitochondria dysfunction in the female Alzheimer's
disease brain: Deficiency of estrogen receptor-β. J Alzheimers Dis.
30:545–558. 2012.PubMed/NCBI
|
|
96
|
Ottowitz WE, Siedlecki KL, Lindquist MA,
Dougherty DD, Fischman AJ and Hall JE: Evaluation of
prefrontal-hippocampal effective connectivity following 24 hours of
estrogen infusion: An FDG-PET study. Psychoneuroendocrinology.
33:1419–1425. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Waters EM, Yildirim M, Janssen WG, Lou WY,
McEwen BS, Morrison JH and Milner TA: Estrogen and aging affect the
synaptic distribution of estrogen receptor β-immunoreactivity in
the CA1 region of female rat hippocampus. Brain Res. 1379:86–97.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Petanceska SS, Nagy V, Frail D and Gandy
S: Ovariectomy and 17beta-estradiol modulate the levels of
Alzheimer's amyloid beta peptides in brain. Neurology.
54:2212–2217. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Anastasio TJ: Exploring the contribution
of estrogen to amyloid-beta regulation: A novel multifactorial
computational modeling approach. Front Pharmacol. 4:162013.
View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Zhang QG, Wang R, Khan M, Mahesh V and
Brann DW: Role of Dickkopf-1, an antagonist of the Wnt/beta-catenin
signaling pathway, in estrogen-induced neuroprotection and
attenuation of tau phosphorylatio. J Neurosci. 28:8430–8441. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Pike CJ: Estrogen modulates neuronal
Bcl-xL expression and beta-amyloidinduced apoptosis: Relevance to
Alzheimer's disease. J Neurochem. 72:1552–1563. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Jung JI, Ladd TB, Kukar T, Price AR, Moore
BD, Koo EH, Golde TE and Felsenstein KM: Steroids as γ-secretase
modulators. FASEB J. 27:3775–3785. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Jayaraman A, Carroll JC, Morgan TE, Lin S,
Zhao L, Arimoto JM, Murphy MP, Beckett TL, Finch CE, Brinton RD and
Pike CJ: 17β-estradiol and progesterone regulate expression of
β-amyloid clearance factors in primary neuron cultures and female
rat brain. Endocrinology. 153:5467–5479. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Sherwin BB and Tulandi T: ‘Add-back’
estrogen reverses cognitive deficits induced by a
gonadotropin-releasing hormone agonist in women with leiomyomata
uteri. J Clin Endocrinol Metab. 81:2545–2549. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Holland J, Bandelow S and Hogervorst E:
Testosterone levels and cognition in elderly men: A review.
Maturitas. 69:322–337. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Gouras GK, Xu H, Gross RS, Greenfield JP,
Hai B, Wang R and Greengard P: Testosterone reduces neuronal
secretion of Alzheimer's beta-amyloid peptides. Proc Natl Acad Sci
USA. 97:1202–1205. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Lau CF, Ho YS, Hung CH, Uwongse S, Poon
CH, Chiu K, Yang X, Chu LW and Chang RC: Protective effects of
testosterone on presynaptic terminals against oligomeric β-amyloid
peptide in primary culture of hippocampal neurons. Biomed Res Int.
2014:1039062014. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Maggio M, Dall'Aglio E, Lauretani F,
Cattabiani C, Ceresini G, Caffarra P, Valenti G, Volpi R, Vignali
A, Schiavi G and Ceda GP: The hormonal pathway to cognitive
impairment in older men. J Nutr Health Aging. 16:40–54. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Nguyen TV, Jayaraman A, Quaglino A and
Pike CJ: Androgens selectively protect against apoptosis in
hippocampal neurones. J Neuroendocrinol. 22:1013–1022. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Pike CJ: Testosterone attenuates
beta-amyloid toxicity in cultured hippocampal neurons. Brain Res.
919:160–165. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Medway C, Combarros O, Cortina-Borja M,
Butler HT, Ibrahim-Verbaas CA, de Bruijn RF, Koudstaal PJ, van
Duijn CM, Ikram MA, Mateo I, et al: The sex-specific associations
of the aromatase gene with Alzheimer's disease and its interaction
with IL10 in the epistasis project. Eur J Hum Genet. 22:216–220.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Holland D, Desikan RS, Dale AM, McEvoy LK,
et al: Alzheimer's Disease Neuroimaging Initiative: Higher rates of
decline for women and apolipoprotein E epsilon4 carriers. AJNR Am J
Neuroradiol. 34:2287–2293. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Morris JC, Roe CM, Xiong C, Fagan AM,
Goate AM, Holtzman DM and Mintun MA: APOE predicts amyloid-beta but
not tau Alzheimer pathology in cognitively normal aging. Ann
Neurol. 67:122–131. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Pietrzak RH, Lim YY, Ames D, Harrington K,
Restrepo C, Martins RN, Rembach A, Laws SM, Masters CL, Villemagne
VL, et al: Trajectories of memory decline in preclinical
Alzheimer's disease: Results from the Australian imaging,
biomarkers and lifestyle flagship study of ageing. Neurobiol Aging.
36:1231–1238. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Morris JC, Roe CM, Grant EA, Head D,
Storandt M, Goate AM, Fagan AM, Holtzman DM and Mintun MA:
Pittsburgh compound B imaging and prediction of progression from
cognitive normality to symptomatic Alzheimer disease. Arch Neurol.
66:1469–1475. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Fleisher A, Grundman M, Jack CR Jr,
Petersen RC, Taylor C, Kim HT, Schiller DH, Bagwell V, Sencakova D,
Weiner MF, et al: Sex, apolipoprotein E epsilon 4 status, and
hippocampal volume in mild cognitive impairment. Arch Neurol.
62:953–957. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Beydoun MA, Beydoun HA, Kaufman JS, An Y,
Resnick SM, O'Brien R, Ferrucci L and Zonderman AB: Apolipoprotein
E ε4 allele interacts with sex and cognitive status to influence
all-cause and cause-specific mortality in US older adults. J Am
Geriatr Soc. 61:525–534. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Payami H, Zareparsi S, Montee KR, Sexton
GJ, Kaye JA, Bird TD, Yu CE, Wijsman EM, Heston LL, Litt M and
Schellenberg GD: Gender difference in apolipoprotein E-associated
risk for familial Alzheimer disease: A possible clue to the
higherincidence of Alzheimer disease in women. Am J Hum Genet.
58:803–811. 1996.PubMed/NCBI
|
|
119
|
Protas HD, Chen K, Langbaum JB, Fleisher
AS, Alexander GE, Lee W, Bandy D, de Leon MJ, Mosconi L, Buckley S,
et al: Posterior cingulate glucose metabolism, hippocampal glucose
metabolism, and hippocampal volume in cognitively normal,
late-middle-aged persons at 3 levels of genetic risk for Alzheimer
disease. JAMA Neurol. 70:320–325. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Stone DJ, Rozovsky I, Morgan TE, Anderson
CP and Finch CE: Increased synaptic sprouting in response to
estrogen via an apolipoprotein E-dependent mechanism: Implications
for Alzheimer's disease. J Neurosci. 18:3180–3185. 1998.PubMed/NCBI
|
|
121
|
Zou F, Gopalraj RK, Lok J, Zhu H, Ling IF,
Simpson JF, Tucker HM, Kelly JF, Younkin SG, Dickson DW, et al:
Sex-dependent association of a common low-density lipoprotein
receptor polymorphism with RNA splicing efficiency in the brain and
Alzheimer's disease. Hum Mol Genet. 17:929–935. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Cagliani R, Guerini FR, Rubio-Acero R,
Baglio F, Forni D, Agliardi C, Griffanti L, Fumagalli M, Pozzoli U,
Riva S, et al: Long-standing balancing selection in the THBS4 gene:
Influence on sex-specific brain expression and gray matter volumes
in Alzheimer disease. Hum Mutat. 34:743–753. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Reynolds CA, Zavala C, Gatz M, Vie L,
Johansson B, Malmberg B, Ingelsson E, Prince JA and Pedersen NL:
Sortilin receptor 1 predicts longitudinal cognitive change.
Neurobiol Aging. 34:1710.e11–e18. 2013. View Article : Google Scholar
|
|
124
|
Sundar PD, Feingold E, Minster RL, DeKosky
ST and Kamboh MI: Gender-specific association of ATP-binding
cassette transporter 1 (ABCA1) polymorphisms with the riskof
late-onset Alzheimer's disease. Neurobiol Aging. 28:856–862. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Kaminsky Z, Wang SC and Petronis A:
Complex disease, gender and epigenetics. Ann Med. 38:530–544. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Laughlin GA and Barrett-Connor E: Sexual
dimorphism in the influence of advanced aging on adrenal hormone
levels: The rancho bernardo study. J Clin Endocrinol Metab.
85:3561–3568. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Nater UM, Hoppmann CA and Scott SB:
Diurnal profiles of salivary cortisol and alpha-amylase change
across the adult lifespan: Evidence from repeated daily life
assessments. Psychoneuroendocrinology. 38:3167–3171. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Yen SS and Laughlin GA: Aging and the
adrenal cortex. Exp Gerontol. 33:897–910. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Heaney JL, Phillips AC and Carroll D:
Ageing, depression, anxiety, social support and the diurnal rhythm
and awakening response of salivary cortisol. Int J Psychophysiol.
78:201–208. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Burke HM, Davis MC, Otte C and Mohr DC:
Depression and cortisol responses to psychological stress: A
meta-analysis. Psychoneuroendocrinology. 30:846–856. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Orentreich N, Brind JL, Rizer RL and
Vogelman JH: Age changes and sex differences in serum
dehydroepiandrosterone sulfateconcentrations throughout adulthood.
J Clin Endocrinol Metab. 59:551–555. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Vermeulen A: Dehydroepiandrosterone
sulfate and aging. Ann NY Acad Sci. 774:121–127. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Parker CR Jr, Mixon RL, Brissie RM and
Grizzle WE: Aging alters zonation in the adrenal cortex of men. J
Clin Endocrinol Metab. 82:3898–3901. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Varadhan R, Walston J, Cappola AR, Carlson
MC, Wand GS and Fried LP: Higher levels and blunted diurnal
variation of cortisol in frail older women. J Gerontol A Biol Sci
Med Sci. 63:190–195. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Holanda CM, Guerra RO, Nóbrega PV, Costa
HF, Piuvezam MR and Maciel ÁC: Salivary cortisol and frailty
syndrome in elderly residents of long-stay institutions:
Across-sectional study. Arch Gerontol Geriatr. 54:e146–e151. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Waters DL, Qualls CR, Dorin RI, Veldhuis
JD and Baumgartner RN: Altered growth hormone, cortisol, and leptin
secretion in healthy elderly persons with sarcopenia and mixed body
composition phenotypes. J Gerontol A Biol Sci Med Sci. 63:536–541.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Schakman O, Gilson H and Thissen JP:
Mechanisms of glucocorticoid-induced myopathy. J Endocrinol.
197:1–10. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Attaix D, Mosoni L, Dardevet D, Combaret
L, Mirand PP and Grizard J: Altered responses in skeletal muscle
protein turnover during aging in anabolic and catabolic periods.
Int J Biochem Cell Biol. 37:1962–1973. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Gupta A and Gupta Y:
Glucocorticoid-induced myopathy: Pathophysiology, diagnosis, and
treatment. Indian J Endocrinol Metab. 17:913–916. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Leng SX, Cappola AR, Andersen RE, Blackman
MR, Koenig K, Blair M and Walston JD: Serum levels of insulin-like
growth factor-I (IGF-I) and dehydroepiandrosterone sulfate
(DHEA-S), and their relationships with serum interleukin-6, in the
geriatric syndrome of frailty. Aging Clin Exp Res. 16:153–157.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Puts MT, Visser M, Twisk JW, Deeg DJ and
Lips P: Endocrine and inflammatory markers as predictors of
frailty. Clin Endocrinol (Oxf). 63:403–411. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Gupta D and Morley JE:
Hypothalamic-pituitary-adrenal (HPA) axis and aging. Compr Physiol.
4:1495–1510. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Giunta S: Exploring the complex relations
between inflammation and aging (inflamm-aging): Anti-inflamm-aging
remodelling of inflamm-aging, from robustness to frailty. Inflamm
Res. 57:558–563. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Ohlsson C, Labrie F, Barrett-Connor E,
Karlsson MK, Ljunggren O, Vandenput L, Mellström D and Tivesten A:
Low serum levels of dehydroepiandrosterone sulfate predict
all-cause and cardiovascular mortality in elderly Swedish men. J
Clin Endocrinol Metab. 95:4406–4414. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Cappola AR, Xue QL, Walston JD, Leng SX,
Ferrucci L, Guralnik J and Fried LP: DHEAS levels and mortality in
disabled older women: The women's health and aging study I. J
Gerontol A Biol Sci Med Sci. 61:957–962. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Voznesensky M, Walsh S, Dauser D, Brindisi
J and Kenny AM: The association between dehydroepiandosterone and
frailty in older men and women. Age Ageing. 38:401–416. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Sanders JL, Cappola AR, Arnold AM,
Boudreau RM, Chaves PH, Robbins J, Cushman M and Newman AB:
Concurrent change in dehydroepiandrosterone sulfate and functional
performance in the oldest old: Results from the cardiovascular
health study all stars study. J Gerontol A Biol Sci Med Sci.
65:976–981. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Carvalhaes-Neto N, Huayllas MK, Ramos LR,
Cendoroglo MS and Kater CE: Cortisol, DHEAS and aging: Resistance
to cortisol suppression in frail institutionalized elderly. J
Endocrinol Invest. 26:17–22. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Lee BK, Glass TA, McAtee MJ, Wand GS,
Bandeen-Roche K, Bolla KI and Schwartz BS: Associations of salivary
cortisol with cognitive function in the Baltimore memory study.
Arch Gen Psychiatry. 64:810–818. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Huang CW, Lui CC, Chang WN, Lu CH, Wang YL
and Chang CC: Elevated basal cortisol level predicts lower
hippocampal volume and cognitive decline in Alzheimer's disease. J
Clin Neurosci. 16:1283–1286. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Seeman TE, McEwen BS, Singer BH, Albert MS
and Rowe JW: Increase in urinary cortisol excretion and memory
declines: MacArthur studies of successful aging. J Clin Endocrinol
Metab. 82:2458–2465. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Comijs HC, Gerritsen L, Penninx BW,
Bremmer MA, Deeg DJ and Geerlings MI: The association between serum
cortisol and cognative decline in older persons. Am J Geriatr
Psychiatry. 18:42–50. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Wolf OT, Schommer NC, Hellhammer DH,
McEwen BS and Kirschbaum C: The relationship between stress induced
cortisol levels and memory differs between men and women.
Psychoneuroendocrinology. 26:711–720. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Eichenbaum H: Hippocampus: Cognitive
processes and neural representations that underlie declarative
memory. Neuron. 44:109–120. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Zacharski LR, Ornstein DL, Woloshin S and
Schwartz LM: Association of age, sex, and racewith body iron stores
in adults: Analysis of NHANES III data. Am Heart J. 140:98–104.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Milman N: Serum ferritin in Danes: Studies
of iron status from infancy to old age, during blood donation and
pregnancy. Int J Hematol. 63:103–135. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Sullivan JL: Iron and the sex difference
in heart disease risk. Lancet. 1:1293–1294. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Sullivan JL: Are menstruating women
protected from heart disease because of, or in spite of, estrogen?
Relevance to the iron hypothesis. Am Heart J. 145:190–194. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Zacharski LR, Chow BK, Howes PS, Shamayeva
G, Baron JA, Dalman RL, Malenka DJ, Ozaki CK and Lavori PW:
Reduction of iron stores and cardiovascular outcomes in patients
with peripheral arterial disease: A randomized controlled trial.
JAMA. 297:603–610. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Milman N and Kirchhoff M: Iron stores in
1359, 30- to 60-year-old Danish women: Evaluation by serum ferritin
and hemoglobin. Ann Hematol. 64:22–27. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Raman SV, Sharkey-Toppen TP, Tran T, Liu
JX, McCarthy B, He X, Smart S, Gulati M, Wexler R, Simonetti OP and
Jackson RD: Iron, inflammation and atherosclerosis risk in men vs.
perimenopausal women. Atherosclerosis. 241:249–254. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Bartzokis G, Tishler TA, Lu PH,
Villablanca P, Altshuler LL, Carter M, Huang D, Edwards N and Mintz
J: Brain ferritin iron may influence age- and gender-related risks
of neurodegeneration. Neurobiol Aging. 28:414–423. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Artz AS: Anemia and the frail elderly.
Semin Hematol. 45:261–266. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Duh MS, Latypova A and Greenberg P: Impact
and treatment of anemia in the elderly: Clinical, epidemiological
and economic perspectives. Expert Rev Pharmacoecon Outcomes Res.
6:577–590. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
MacKenzie EL, Iwasaki K and Tsuji Y:
Intracellular iron transport and storage: From molecular mechanisms
to health implications. Antioxid Redox Signal. 10:997–1030. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Xu J, Knutson MD, Carter CS and
Leeuwenburgh C: Iron accumulation with age, oxidative stress and
functional decline. PLoS One. 3:e28652008. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Sullivan JL: Is stored iron is safe ? J
Lab Clin Med. 144:280–284. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Bartzokis G, Lu PH, Tingus K, Peters DG,
Amar CP, Tishler TA, Finn JP, Villablanca P, Altshuler LL, Mintz J,
et al: Gender and iron genes may modify associations between brain
iron and memory in healthy aging. Neuropsychopharmacology.
36:1375–1384. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Smith MA, Zhu X, Tabaton M, Liu G, McKeel
DW Jr, Cohen ML, Wang X, Siedlak SL, Dwyer BE, Hayashi T, et al:
Increased iron and free radical generation in preclinical Alzheimer
disease and mild cognitive impairment. J Alzheimers Dis.
19:363–372. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Kell DB: Iron behaving badly:
Inappropriate iron chelation as a major contributor to the
aetiology of vascular and other progressive inflammatory and
degenerative diseases. BMC Med Genomics. 2:22009. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Ayton S, Faux NG and Bush AI: Alzheimer's
disease neuroimaging initiative: Ferritin levels in the
cerebrospinal fluid predict Alzheimer's disease outcomes and are
regulated by APOE. Nat Commun. 6:67602015. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Berge LN, Bønaa KH and Nordøy A: Serum
ferritin, sex hormones, and cardiovascular risk factors in healthy
women. Arterioscler Thromb. 14:857–861. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Mascitelli L, Goldstein MR and Pezzetta F:
Explaining sex difference in coronary heart disease: Is it time to
shift from the oestrogen hypothesis to the ironhypothesis? J
Cardiovasc Med (Hagerstown). 12:64–65. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Masse PG, Dosy J, Cole DE, Evroski J,
Allard J and D'Astous M: Is serum ferritin an additional
cardiovascular risk factor for all postmenopausal women? Ann Nutr
Metab. 48:381–389. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Qian Y, Yin C, Chen Y, Zhang S, Jiang L,
Wang F, Zhao M and Liu S: Estrogen contributes to regulating iron
metabolism through governing ferroportin signaling via an
estrogenresponse element. Cell Signal. 27:934–942. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Hou Y, Zhang S, Wang L, Li J, Qu G, He J,
Rong H, Ji H and Liu S: Estrogen regulates iron homeostasis through
governing hepatic hepcidin expression via an estrogen response
element. Gene. 511:398–403. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Yang Q, Jian J, Katz S, Abramson SB and
Huang X: 17β-Estradiol inhibits iron hormone hepcidin through an
estrogen responsive element half-site. Endocrinology.
153:3170–3178. 2012. View Article : Google Scholar : PubMed/NCBI
|
